Page 3 - INFORMATION FOR HEALTH CARE PROFESSIONALS

Information for Health Care Professionals

Cannabis (marihuana, marijuana) and the cannabinoids
Dried or fresh plant and oil for administration by ingestion or other means
Psychoactive agent

This document has been prepared by the Cannabis Legalization and Regulation
Branch at Health Canada to provide information on the use of cannabis
(marihuana) and cannabinoids for medical purposes. This document is a
summary of peer-reviewed literature and international reviews concerning
potential therapeutic uses and harmful effects of cannabis and cannabinoids. It
is not meant to be comprehensive and should be used as a complement to other
reliable sources of information. This document is not a systematic review or
meta-analysis of the literature and has not rigorously evaluated the quality and
weight of the available evidence nor has it graded the level of evidence.
Despite the similarity of format, it is not a Drug Product Monograph, which is
a document which would be required if the product were to receive a Notice of
Compliance authorizing its sale in Canada.

This document should not be construed as expressing conclusions or
opinions from Health Canada about the appropriate use of cannabis
(marihuana) or cannabinoids for medical purposes.

Cannabis is not an approved therapeutic product, unless a specific
cannabis product has been issued a drug identification number (DIN) and
a notice of compliance (NOC). The provision of this information should
not be interpreted as an endorsement of the use of this product, or
cannabis and cannabinoids generally, by Health Canada.

Prepared by Health Canada

Date of latest version: Spring 2018

iii